[Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx].
Between January 1985 and December 1986 320 patients previously treated for squamous cell carcinoma of the oral cavity, pharynx or larynx made 1200 follow-up visits. During this period 25 recurrences, 4 distant metastases and 2 second primaries were diagnosed. Seven patients received further treatment with curative intention, but only 4 patients are alive with no evidence of disease 3 to 23 months after salvage surgery. Indiscriminate follow-up of all patients with head and neck carcinoma over an extended period of time does not appear to be warranted.
Wolfensberger
M
M
Klinik für Otorhinolaryngologie, Hals- und Gesichtschirurgie, Universitätsspitals Zürich.
D000359:Aftercare / Q000379:methods*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D007822:Laryngeal Neoplasms / Q000628:therapy*; D007825:Laryngectomy; D009062:Mouth Neoplasms / Q000628:therapy*; D037981:Neck Dissection; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000628:therapy; D010610:Pharyngeal Neoplasms / Q000628:therapy*; D012017:Referral and Consultation
Aufwand und Nutzen regelmässiger Nachkontrollen bei Patienten mit Pflasterzellkarzinomen des Larynx, der Mundhöhle und des Pharynx.